Powered by
DETROIT–Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for cancer survivors, according to a new study by researchers at Barbara …
ANN ARBOR—Officials at HistoSonics, developer of novel ultrasound therapies, announced today that the first patient has been treated as part of the company’s #HOPE4LIVER Europe Trial, which was approved by …
DETROIT—Officials at the Karmanos Cancer Institute in Detroit have announced the launch of a new clinical trials study information portal (SIP) at www.karmanos.org/opentrials. The SIP website, which is integrated with …
ANN ARBOR—HistoSonics Inc. announced that it had received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin a clinical trial of its new technology, …
ROYAL OAK — Proton International and Beaumont Health have opened the state’s first proton therapy center, offering an advanced form of radiation treatment available to people with a wide range …
DETROIT — A new medical study co-authored by DMC Heart Hospital vice president Cindy L. Grines, M.D., shows that treating cancer frequently triggers later heart disease. Grines, who is also …